Publication | Closed Access

Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors

Biological ActivityOncologyBreast Cancer PatientsMedicinePathologyTumor TargetingCancer TreatmentP53-overexpressing TumorsCancer BiologyRadiation OncologyCancer ResearchTumor BiologyCancer-associated Virus